NCT03161522View on ClinicalTrials.gov

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 19, 2018

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Gastric AdenocarcinomaOligometastasisStage IV Esophageal Adenocarcinoma AJCC v7Stage IV Esophageal Cancer AJCC v7Stage IV Gastric Cancer AJCC v7
Interventions
DRUG

Capecitabine

Patients will receive 5-fluorouracil (5-FU) and capecitabine as maintenance chemotherapy.

DRUG

Chemotherapy

Receive induction chemotherapy

PROCEDURE

Conventional Surgery

Undergo surgery

DRUG

Fluorouracil

Patients will receive 5-fluorouracil (5-FU) and capecitabine as maintenance chemotherapy.

RADIATION

Radiation Therapy

Undergo RT

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER